Related references
Note: Only part of the references are listed.Light-triggered dual-modality drug release of self-assembled prodrug-nanoparticles for synergistic photodynamic and hypoxia-activated therapy
Dongyang Zhao et al.
NANOSCALE HORIZONS (2020)
ROS self-generation and hypoxia self-enhanced biodegradable magnetic nanotheranostics for targeted tumor therapy
Jinghua Li et al.
NANOSCALE HORIZONS (2020)
Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Xiaopin Duan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor
Soo Zeng Fiona Phua et al.
ACS NANO (2019)
Alternative and Injectable Preformed Albumin-Bound Anticancer Drug Delivery System for Anticancer and Antimetastasis Treatment
Chuchu Zhou et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
A Three-in-One Immunotherapy Nanoweapon via Cascade-Amplifying Cancer-Immunity Cycle against Tumor Metastasis, Relapse, and Postsurgical Regrowth
Qian Li et al.
NANO LETTERS (2019)
Biomimetic Metal-Organic Framework Nanoparticles for Cooperative Combination of Antiangiogenesis and Photodynamic Therapy for Enhanced Efficacy
Huan Min et al.
ADVANCED MATERIALS (2019)
Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics
Priti S. Hegde et al.
SEMINARS IN CANCER BIOLOGY (2018)
Regulatory T cells: a potential target in cancer immunotherapy
Kohei Shitara et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models
Heinz Laubli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Supramolecular photosensitizers rejuvenate photodynamic therapy
Xingshu Li et al.
CHEMICAL SOCIETY REVIEWS (2018)
Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer
Cheng-Liang Peng et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2018)
Improving immune-vascular crosstalk for cancer immunotherapy
Yuhui Huang et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Differential effects of recombinant human endostatin treatment on differentiated and undifferentiated blood vessels in Lewis lung cancer
Weijiang Fu et al.
ONCOLOGY LETTERS (2017)
Albumin-coated nanocrystals for carrier-free delivery of paclitaxel
Joonyoung Park et al.
JOURNAL OF CONTROLLED RELEASE (2017)
A metal-semiconductor nanocomposite as an efficient oxygen-independent photosensitizer for photodynamic tumor therapy
Jin-Xuan Fan et al.
NANOSCALE HORIZONS (2017)
Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy
Tingting Lin et al.
ACS NANO (2016)
Intelligent Albumin-MnO2 Nanoparticles as pH-/H2O2-Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination Therapy
Qian Chen et al.
ADVANCED MATERIALS (2016)
Role of Achiral Nucleobases in Multicomponent Chiral Self-Assembly: Purine-Triggered Helix and Chirality Transfer
Ming Deng et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion
Stephanie Du Four et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy
Zhibo Liu et al.
CHEMICAL SOCIETY REVIEWS (2016)
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2016)
Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
Qian Chen et al.
NATURE COMMUNICATIONS (2016)
Avasimibe Encapsulated in Human Serum Albumin Blocks Cholesterol Esterification for Selective Cancer Treatment
Steve Seung-Young Lee et al.
ACS NANO (2015)
Docetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanism
Bryan Hoang et al.
BIOMATERIALS (2015)
Binding and Anticancer Properties of Plumbagin with Human Serum Albumin
Yi Gou et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2015)
Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model
Stephanie Du Four et al.
ONCOIMMUNOLOGY (2015)
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Rakesh K. Jain
CANCER CELL (2014)
Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
George C. Prendergast et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Stromal expression of SPARC in pancreatic adenocarcinoma
Cindy Neuzillet et al.
CANCER AND METASTASIS REVIEWS (2013)
Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
Yuhui Huang et al.
CANCER RESEARCH (2013)
Deciphering and Reversing Tumor Immune Suppression
Greg T. Motz et al.
IMMUNITY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells
Isil Altintas et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Axitinib for the Management of Metastatic Renal Cell Carcinoma
Bernard Escudier et al.
Drugs in research & development (2013)
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2
N. G. Gavalas et al.
BRITISH JOURNAL OF CANCER (2012)
Tracer-cocktail injections for combined pre- and intraoperative multimodal imaging of lymph nodes in a spontaneous mouse prostate tumor model
Anne C. van Leeuwen et al.
JOURNAL OF BIOMEDICAL OPTICS (2011)
Trimodal Glioblastoma Treatment Consisting of Concurrent Radiotherapy, Temozolomide, and the Novel TGF-β Receptor I Kinase Inhibitor LY2109761
Mengxian Zhang et al.
NEOPLASIA (2011)
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Stefan Loeb et al.
NATURE REVIEWS CANCER (2009)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Photodynamic therapy and anti-tumour immunity
Ana P. Castano et al.
NATURE REVIEWS CANCER (2006)
Mechanisms in photodynamic therapy: Part three- Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction
Ana P. Castano et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Overcoming tumor-intrinsic resistance to immune effector function
R Ganss et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Tumorigenesis and the angiogenic switch
G Bergers et al.
NATURE REVIEWS CANCER (2003)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Share Paper
